Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles
Lifestyles
Alimentation
Alimentation
Health-promoting environments
Back
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Drugs and medicines
Opioid overdoses
Back
Tobacco and electronic cigarettes
Tobacco and electronic cigarettes
Science Watch : Tobacco Control
Back
Back
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental Health
Environmental Health
Air quality
Air quality
Indoor air
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Respiratory viruses survey
Complete the survey (period from October 19 to 25, 2025)
Back
Exit
Back
Danger page
Search
Search by keywords
Content type
Content type
Data
Internship
Laboratory analysis
News
Newsletter
Page
Publication
Tiny Tot
Training
Nicole Boulianne
Publications
INSPQ
2021
Efficacité d’une dose de vaccin contre la COVID-19 chez les personnes de 60 ans et plus vivant dans la communauté au Québec
Impact de la première dose de vaccin contre la COVID-19 dans les CHSLD et les RPA
2019
Enquête sur la couverture vaccinale des enfants québécois pour les vaccins administrés avant l’entrée scolaire, 2017
2018
Impact du programme d’immunisation contre les maladies invasives à pneumocoque au Québec, 2010-2014
Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2016
2016
Épidémiologie descriptive des maladies à déclaration obligatoire évitables par la vaccination au Québec, 2011-2013
Estimation des hospitalisations attribuables à l’influenza selon différentes méthodes
2015
Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2014
Couverture vaccinale et âge à la vaccination avant l'éclosion de rougeole de 2011 au Québec et impact de l'Opération rougeole
2014
Vaccination contre l'influenza des 6-23 mois au Québec : pistes de réflexion
2013
Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2012
2012
Évaluation de l'implantation du Programme de vaccination contre les virus du papillome humain (VPH) chez les adolescentes du Québec
Impact du programme d'immunisation par le vaccin pneumococcique conjugué heptavalent (VPC-7) au Québec
2011
Fardeau de la varicelle et du zona au Québec, 1990-2008 : impact du programme universel de vaccination
Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2010
Avis du Groupe scientifique en immunisation sur les indicateurs des retards vaccinaux au Québec
Plan d'action pour la promotion de la vaccination au Québec
2010
Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2008
Plan québécois de promotion de la vaccination
Enquête québécoise sur les couvertures vaccinales contre l'influenza et le pneumocoque, 2005-2006
Enquête québécoise sur les couvertures vaccinales contre l'influenza et le pneumocoque, 2008
2008
Impact du programme d'immunisation par le vaccin pneumococcique conjugué heptavalent (VPC-7), au Québec, Canada
2007
Enquête sur la couverture vaccinale des enfants québécois en 2006
2005
Protection contre l'hépatite A et B conférée par deux doses de Recombivax 2,5 μg ou deux doses de Twinrix junior chez des enfants âgés de 8 à 10 ans
2004
Mise en place du fichier de vaccination contre le méningocoque (FVM) : campagne massive de vaccination (Septembre 2001 - Mai 2002)
Système d'information sur la vaccination - Cadre de référence
2003
Enquête québécoise sur les couvertures vaccinales contre l'influenza et le pneumocoque, 2001-2002
2002
Rapport sur l'utilisation d'un vaccin contre la varicelle au Québec
Scientific papers
2021
Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
2019
Promoting vaccination in maternity wards ─ motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015
Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol
2018
Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada
Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada
Impact of the addition of new vaccines in the early childhood schedule on vaccine coverage by 24 months of age from 2006 to 2016 in Quebec, Canada
Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada
Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine
2017
Evaluation of the New World Health Organization Case Definition of Severe Acute Respiratory Infection for Influenza Surveillance During the Peak Weeks of Two Influenza Seasons in Quebec, Canada.
Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
2015
Promoting vaccination: implementation of targeted interventions to enhance access to vaccination services in Quebec (Canada).
Parents' and adolescents' willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec).
Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada
Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.
2014
Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season
Seasonal influenza vaccination uptake in Quebec, Canada, 2 years after the influenza A(H1N1) pandemic
2013
Measles in children vaccinated with 2 doses of MMR
Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine
Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events
Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine
2012
Determinants of parents' decision to vaccinate their children against rotavirus: results of a longitudinal study
Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age
Clinicians' opinions on new vaccination programs implementation
2011
Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children
Acute otitis media and its prevention by immunization: a survey of Canadian pediatricians' knowledge, attitudes and beliefs
Canadian paediatricians' opinions on rotavirus vaccination
A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign
2010
Contagious period for pandemic (H1N1) 2009
Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine
2009
Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later
2006
Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program
2005
Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children
Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country
2003
Why are some children incompletely vaccinated at the age of 2?
A population-based comparison between travelers who consulted travel clinics and those who did not
2002
Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose
Ineffectiveness of the current strategy to prevent hepatitis A in travelers
2001
Most ten-year-old children with negative or unknown histories of chickenpox are immune
Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine
Lack of conviction about vaccination in certain Quebec vaccinators
Importance of attributable risk in monitoring adverse events after immunization: hepatitis B vaccination in children
Government of Quebec
Government of Quebec
